The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
4503259 5675000 I 4503259-5 20030201 20041108 20041117 EXP US-MERCK-0411USA01417 MERCK HUMAN HEALTH DIVISION 50 YR M Y 20041117 PH

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
4503259 1005394858 PS INVANZ 1 INTRAVENOUS

Indications of drugs used

Event ID DRUG SEQ INDI PT
4503259 1005394858 DIABETIC FOOT INFECTION

Outcome of event

Event ID OUTC COD
4503259 DE
4503259 OT

Reactions reported

Event ID PT
4503259 CONVULSION
4503259 CREATININE RENAL CLEARANCE DECREASED
4503259 DEATH
4503259 FOOT AMPUTATION
4503259 HYPERKALAEMIA
4503259 HYPOCALCAEMIA

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
4503259 1005394858 20030201